Budesonide izhekhayler powder for inhalation 0.2 mg/dose 200 doses 2.5 g

Indications

Bronchial asthma requiring maintenance therapy with glucocorticoids.

Dosing regimen

In the case of inhalation use, the dose is established depending on the indications, age, method of inhalation.

Side effect

Respiratory: with inhalation use, irritation of the mucous membranes of the pharynx, oral cavity, nose, candidiasis is possible; with hypersensitivity - bronchospasm.

Contraindications

Hypersensitivity to Budesonide.

Use during pregnancy and lactation

Use during pregnancy is possible in the case when the intended benefit to the mother outweighs the potential risk to the fetus.

If necessary, use during lactation, should stop breastfeeding, due to the lack of data on the allocation of budesonide with breast milk.

Use in children

The efficacy and safety of budesonide in children under the age of 7 years has not been studied.

special instructions

It is used with caution in patients with pulmonary tuberculosis, as well as in chickenpox.

Budesonide is not intended for the relief of acute asthma attacks in bronchial asthma. Not recommended for use in the intermittent course of the disease.

The replacement of systemic corticosteroids by inhalation is carried out gradually.

The efficacy and safety of budesonide in children under the age of 7 years has not been studied.

Influence on ability to drive motor transport and control mechanisms

Budesonide does not affect the ability to engage in potentially hazardous activities that require increased attention and high-speed psychomotor reactions.

Drug interaction

Cimetidine and Omeprazole have no clinically significant effect on the pharmacokinetic parameters of budesonide when administered orally. However, under the influence of cimetidine may slow the metabolism of budesonide in the liver.